"Calibration" action speeds up high-risk level fund products are no longer hidden

In what appears to be a calm fund announcement column, a "calibration" action related to the underlying logic of the industry is quietly accelerating. Since the beginning of this year, more than 10 public offering institutions including CEB Fund, Huaxia Fund, and Yongyin Fund have made intensive adjustments to more than 200 products' risk levels, moving a large number of equity products from the R3 range to the R4 range. This is not only a technical calibration of the rating agencies' delineation of "position red lines", but also a positive response to the regulatory requirement of "penetrating to the bottom" aiming to break the "mismatch" between the positioning of past products and actual investments, promote accurate alignment of fund risk levels with the underlying asset's volatility characteristics, and further consolidate the institutional foundation for protecting investors' rights and interests. Some industry insiders have stated that, with the continuous refinement of product suitability management, the public offering fund industry is undergoing a deep standardization operation. This is not only a strong response to regulatory policies, but also a necessary path to break information asymmetry and truly protect the interests of investors.